Skip to main navigation
Skip to content
Sensei Biotherapeutics
Clinical-Stage Biotechnology
Investor Relations
About
Pipeline
Overview
SNS-301
SNS-401
Vista
Presentations
Platform
Immunophage
Therapeutic cocktails
Phortress
Immunophage + Nanobodies
GMP Manufacturing
Publications
Our Leadership
Senior Leadership
Board Of Directors
Immuno Oncology Advisory Board
Careers
Investors and Media
News Releases
Events & Presentations
Corporate Governance
Governance Overview
Board of Directors
Management
Committee Composition
Financial Information
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analyst Coverage
Shareholder Services
Investor FAQs
Email Alerts
RSS Feeds
Contact Us
Contact
Investor Relations
About
Pipeline
Overview
SNS-301
SNS-401
Vista
Presentations
Platform
Immunophage
Therapeutic cocktails
Phortress
Immunophage + Nanobodies
GMP Manufacturing
Publications
Our Leadership
Senior Leadership
Board Of Directors
Immuno Oncology Advisory Board
Careers
Investors and Media
News Releases
Events & Presentations
Corporate Governance
Governance Overview
Board of Directors
Management
Committee Composition
Financial Information
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analyst Coverage
Shareholder Services
Investor FAQs
Email Alerts
RSS Feeds
Contact Us
Contact Us
Investor Contact:
Erin Colgan
ir@senseibio.com
Name
Email
Subject
Comments
Leave this field blank
Investor Tools
Email Alerts
Investor FAQs
RSS Feeds
Contact Us
Go to Top